GSK will close manufacturing plant in Ireland, cutting 165 jobs

It's the second such announcement this month for GSK, which earlier said it would shutter a Bangladesh plant resulting in more than 1,000 layoffs.

By Barbara Boughton • Aug. 21, 2018

Trump seeks federal opioid lawsuit, DOJ aims to slash manufacturing quotas

The president said he'd like Attorney General Jeff Sessions to launch a federal suit in addition to ongoing state legal actions. Meanwhile, the DOJ and DEA proposed further cuts to quotas on opioids for 2019.

By Andrew Dunn • Aug. 17, 2018

Mylan's EpiPen supply woes drag on

In the midst of a strategic review, Mylan is still having problems with EpiPen supplies. The new approval of Teva's generic only makes the situation even more dire.

By Suzanne Elvidge • Aug. 16, 2018

After a hiring blitz, where is Mustang's CAR-T manufacturing headed?

On the heels of a new plant opening and licensing deal, Chief Technology Officer Knut Niss discussed lessons learned and the road ahead for Mustang.

By Jacob Bell • Aug. 16, 2018

Roche's Genentech planning to lay off 223 employees

Genentech already cut 365 total workers last November and now plans to eliminate hundreds more as Roche braces for biosimilars to erode some of its top brands.

By Andrew Dunn • Aug. 16, 2018

FDA sends Apotex warning letter for Indian manufacturing violations

Another warning heads out to an Indian facility in what is becoming a bumper year for Asian manufacturing violations.

By Suzanne Elvidge • Aug. 16, 2018

Catalent completes $130M acquisition of Juniper

The deal is the latest in the CDMO space aimed at beefing up services for pharmaceutical companies.

By Barbara Boughton • Aug. 15, 2018

With Mylan reeling, Kaléo touts its EpiPen rival for back-to-school season

Manufacturing delays at a Pfizer-owned EpiPen plant have created an opportunity for Kaléo.

By Nick Paul Taylor • Aug. 15, 2018

Torque touts modular approach to T cell manufacturing

Dubbed "Slipstream," Torque's platform is designed to be scalable and less labor-intensive than current cell manufacturing methods.

By Suzanne Elvidge • Aug. 9, 2018

Boehringer, Oxford BioMedica join on CF gene therapy project

Securing Oxford BioMedica's participation is indicative of the manufacturing hurdles present in gene therapy, particularly involving lentiviral vectors. 

By Suzanne Elvidge • Aug. 9, 2018

Manufacturing problems leave Jazz with 'extremely limited' Erwinaze supply

Issues at the drug's single-source provider, Porton Biopharma, have begun to impact Jazz's commercialization of the drug.

By Jacob Bell • Aug. 9, 2018

J&J, Bayer to shutter production plants in South Korea: report

The shutdowns are due to rising labor costs and shifting demand in the pharmaceutical market, writes The Korea Times. 

By Barbara Boughton • Aug. 9, 2018

Teva confident migraine drug will launch this year despite new manufacturing woes

On Tuesday, contract manufacturer Celltrion disclosed it received a Form 483 for its plant in Incheon, South Korea, which makes Teva's fremanezumab.

By Jacob Bell • Aug. 7, 2018

Changing clinical trial protocols to ensure success

The "eureka moment" that helped a small company make a big impact.

Aug. 6, 2018

Success for ADMA as Bivigam inspection file closes

ADMA Biologics has given Biotest's Bivigam a new lease on life by optimizing the production process and getting a manufacturing go-ahead from the FDA.

By Suzanne Elvidge • Aug. 2, 2018

GSK cuts 1,000 jobs with Bangladesh plant closure

Shuttering of pharmaceutical operations in Chittagong will take effect by year's end and impact employees in marketing and commercial operations.

By Suzanne Elvidge • Aug. 1, 2018

3 blockchain applications to watch in logistics

Complex supply chains make the logistics industry a prime proving ground for blockchain — a technology that could also be useful for pharmaceuticals.

By Deborah Abrams Kaplan • July 30, 2018

Sun Pharma recalls metformin tablets after finding contamination

In response to reports that one metformin HCl tablet had a piece of rubber glove in it, the Indian pharma's U.S. arm is recalling more than 2,500 bottles.

By Suzanne Elvidge • July 30, 2018

FDA puts clinical hold on Sarepta's DMD gene therapy program

The biotech has already created a plan to address the issue, with the aim of dosing patients by the end of 2018 pending an FDA go-ahead.

By Suzanne Elvidge • July 27, 2018

Pfizer to invest $465M in Michigan plant

A new sterile injectable manufacturing facility in the state is expected to start production in 2024, adding jobs to the area.

By Lisa LaMotta • July 26, 2018

Rubius buys manufacturing facility, to invest $155M

The Massachusetts-based biotech made the facility announcement the same week it raised $277 million through its IPO.

By Andrew Dunn • July 26, 2018

WuXi and Antengene sign cancer manufacturing agreement

In a deal focusing on China and the Asia-Pacific, WuXi will provide CMC services from preclinical to commercial.

By Suzanne Elvidge • July 26, 2018

FDA increases regulation on compounded drugs, issues new warning

The agency continues to increase its oversight of compounding, alerting the public to the risk of using cesium chloride as a bulk drug substance. 

By Andrew Dunn • July 26, 2018

Cambrex builds CDMO offerings with $425M Halo buy

By buying Halo, the API maker will add capabilities in specialized dosage forms as well as acquire two manufacturing plants. 

By Lisa LaMotta • July 23, 2018

Novartis hits CAR-T manufacturing snag as Kymriah sales disappoint

Details were scant on "variability in production specifications," but the pharma said it was still able to deliver final product to most patients.

By Ned Pagliarulo • July 19, 2018